文献速递临床免疫临床微生物分子诊断

印尼万隆高危人群TB-Feron检测与QFT-Plus阳性率及一致性评估

Standard E TB-Feron ELISA and Standard F TB-Feron FIA positivity rates and agreement with QuantiFERON-TB Gold Plus among TB high-risk population in Bandung, Indonesia.
PubMed 文献 · J Clin Microbiol · 2025-03-07

该横断面研究纳入527名结核高危者,比较Standard E TB-Feron ELISA、Standard F TB-Feron FIA与QuantiFERON-TB Gold Plus的阳性率及一致性。细菌学确诊结核患者中三种方法阳性率分别为53.3%、60.0%和66.7%,TB-Feron FIA与QFT-Plus总体一致性为84.1%(κ=0.66)。两种TB-Feron检测与QFT-Plus临床性能相当,可作为结核感染检测的替代方法。

要点

  • 在细菌学确诊结核患者中,TB-Feron FIA、TB-Feron ELISA和QFT-Plus阳性率分别为53.3%、60.0%和66.7%。
  • TB-Feron FIA与QFT-Plus总体一致性为84.1%(κ=0.66,95%CI 0.59-0.72)。
  • 两种TB-Feron检测与QFT-Plus临床性能相当,可作为结核感染检测的替代选择。

核心结论

  • TB-Feron FIA和TB-Feron ELISA与QFT-Plus相比显示可接受的临床性能,可作为检测结核感染的替代方法。

研究设计与样本

  • 横断面研究,纳入印度尼西亚万隆市527名结核高危人群,筛查结核症状并行胸部X线,有咳嗽或X线提示结核者留痰行GeneXpert MTB/RIF Ultra检测。

主要发现

  • 细菌学确诊结核患者中,TB-Feron FIA阳性8例(53.3%,95%CI 26.6-78.7),TB-Feron ELISA阳性9例(60.0%,95%CI 32.3-83.7),QFT-Plus阳性10例(66.7%,95%CI 38.4-88.8)。
  • 所有受试者中TB-Feron FIA与QFT-Plus的一致性为84.1%(κ=0.66,95%CI 0.59-0.72),与TB-Feron ELISA和QFT-Plus的一致性相似。

关键数值与推荐

  • 细菌学确诊结核患者中TB-Feron FIA阳性率53.3%(95%CI 26.6-78.7)。
  • 细菌学确诊结核患者中TB-Feron ELISA阳性率60.0%(95%CI 32.3-83.7)。
  • 细菌学确诊结核患者中QFT-Plus阳性率66.7%(95%CI 38.4-88.8)。
  • TB-Feron FIA与QFT-Plus总体一致性84.1%(κ=0.66,95%CI 0.59-0.72)。

临床怎么用

  • 在资源有限地区的高危人群中,TB-Feron FIA和TB-Feron ELISA可作为QFT-Plus的替代方法用于检测结核感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tuberculosis (TB) remains a global public health problem. The determination of tuberculosis infection (TBI) using interferon-gamma release assay has now been used widely. We aim to evaluate the positivity rates of Standard E TB-Feron enzyme-linked immunosorbent assay (TB-Feron ELISA) and Standard F TB-Feron fluorescent immunoassay (TB-Feron FIA) and their agreement with QuantiFERON-TB Gold Plus (QFT-Plus) among TB high-risk populations in Bandung City, Indonesia. We conducted a cross-sectional study, including people with a high risk of acquiring TB. We screened subjects for TB symptoms and offered chest X-ray (CXR). Anyone with cough or CXR suggestive of TB was asked to give sputum samples for GeneXpert MTB/RIF Ultra test. The positivity rates and corresponding 95% confidence intervals (CI) were calculated among patients with bacteriologically confirmed TB and among patients with no evidence of TB, no history of TB, and no known contact with TB patient (low risk of TBI). The agreement with QFT-Plus was calculated using Cohen's κ score. We enrolled 527 subjects, and the proportion of positive results among bacteriologically confirmed TB patients were 8 (53.3%; 95% CI 26.6-78.7), 9 (60.0%, 95% CI 32.3-83.7), and 10 (66.7%, 95% CI 38.4-88.8) by TB-Feron FIA, TB-Feron ELISA and QFT-Plus. The agreement between TB-Feron FIA and QFT-Plus among all subjects was similar to that of TB-Feron ELISA and QFT-Plus (84.1%, κ = 0.66, 95% CI 0.59-0.72). TB-Feron FIA and TB-Feron ELISA showed an acceptable clinical performance compared with QFT-Plus. These tests are useful alternatives for detecting TB infection.IMPORTANCEThis study evaluates the performance of two alternative interferon-gamma release assays, Standard E TB-Feron enzyme-linked immunosorbent assay and Standard F TB-Feron fluorescent immunoassay, for diagnosing tuberculosis infection (TBI) among high-risk populations in Bandung, Indonesia. Both assays demonstrated comparable clinical performance to the widely used QuantiFERON-TB Gold Plus (QFT-Plus). Given the global burden of tuberculosis, particularly in resource-limited settings, these findings suggest that the TB-Feron assays could serve as reliable alternatives to QFT-Plus for TBI detection. This research highlights the potential for these assays to improve tuberculosis diagnosis, offering a more accessible and efficient screening tool, especially for high-risk populations, and supporting broader tuberculosis surveillance.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Turbawaty DK, Maulida SN, Anadhea DR, et al. Standard E TB-Feron ELISA and Standard F TB-Feron FIA positivity rates and agreement with QuantiFERON-TB Gold Plus among TB high-risk population in Bandung, Indonesia. J Clin Microbiol. 2025. PMID: 40052808. doi:10.1128/jcm.01486-24

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。